Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 107110

In scope icon M 4 E
QID 107110 (Type "107110" in App Search)
A 66-year old man with a 45-pack-year smoking history presents with abdominal pain and constipation. He reports that he has had a worsening cough for several months and has lost 20 pounds over this time period. You order a complete metabolic profile, which demonstrates hypercalcemia. A chest radiograph shows a centrally located mass suspicious for malignancy. Which of the following is the most likely explanation?

Squamous cell carcinoma producing parathyroid hormone

35%

85/242

Squamous cell carcinoma producing a peptide with hormonal activity

49%

119/242

Carcinoid tumor causing carcinoid syndrome

0%

1/242

Metastatic abdominal cancer

0%

1/242

Small cell carcinoma producing a peptide with hormonal activity

10%

25/242

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This man is presenting with hypercalcemia in the setting of smoking-associated lung cancer. This is most likely due to squamous cell carcinoma (SCC) producing parathyroid hormone related peptide.

SCC of the lung occurs more commonly in men and has a strong link to smoking. It usually presents with a central (hilar) cavitating lesion. SCC can ectopically secrete PTH-related protein (PTHrP), which has effects similar to parathyroid hormone and can cause hypercalcemia and hypophosphatemia. SCC has a unique histology which includes keratin pearls and intercellular bridges. The treatment for SCC of the lung involves surgical resection if possible and may involve radiation and/or chemotherapy.

Carroll and Schade discuss hypercalcemia due to malignancy. PTHrP is the main cause associated with hypercalcemia in malignancy with solid tumors. PTHrP has a terminus that is similar to PTH at the receptor-binding domain and thus is able to bind to and activate PTH receptors. Serum PTH levels will generally be low in these patients, as negative feedback suppresses endogenous PTH secretion.

Donovan et al. retrospectively reviewed the causes of PTHrP-caused hypercalcemia from a registry at their institution. The authors found that 83% of cases were due to a solid organ malignancy, with SCC and adenocarcinomas being the two leading causes. The authors also found cases associated with myxoid sarcoma, plasma cell leukemia, Merkel cell carcinoma, and epithelioid hemangioendothelioma.

Illustration A depicts a gross pathological specimen of a squamous cell carcinoma of the lung. Note the central location of the tumor.

Incorrect Answers:
Answer 1: Hypercalcemia in SCC is due to PTHrP, not PTH. Indeed, PTH levels are likely suppressed due to negative feedback (caused by the hypercalcemia) suppressing endogenous PTH secretion.
Answer 3: Carcinoid syndrome presents with flushing and diarrhea, not constipation.
Answer 4: The patient has a primary lung malignancy and no indication of metastatic abdominal cancer.
Answer 5: Small cell carcinoma is associated with ACTH production.

ILLUSTRATIONS:
REFERENCES (2)
Authors
Rating
Please Rate Question Quality

2.2

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(5)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options